Herriot Tabuteau
2019
In 2019, Herriot Tabuteau earned a total compensation of $4.7M as Chief Executive Officer and Chairman of the Board at Axsome Therapeutics, a 346% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $326,250 |
|---|---|
| Option Awards | $3,954,503 |
| Salary | $435,000 |
| Total | $4,715,754 |
Tabuteau received $4M in option awards, accounting for 84% of the total pay in 2019.
Tabuteau also received $326.3K in non-equity incentive plan and $435K in salary.
Rankings
In 2019, Herriot Tabuteau's compensation ranked 2,389th out of 13,971 executives tracked by ExecPay. In other words, Tabuteau earned more than 82.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,389 out of 13,971 | 83rd |
Division Manufacturing | 864 out of 5,692 | 85th |
Major group Chemicals And Allied Products | 280 out of 2,189 | 87th |
Industry group Drugs | 225 out of 1,875 | 88th |
Industry Pharmaceutical Preparations | 165 out of 1,387 | 88th |
Pay ratio
| Herriot Tabuteau's Pay | $4,715,754 |
|---|---|
| Median Employee's Pay | $166,021 |
| Pay Ratio | 28to 1 |
In 2019, the annual total compensation of Herriot Tabuteau was $4,715,754.
The annual total compensation of the median employee at Axsome Therapeutics was $166,021.
The ratio of Herriot Tabuteau's pay to the pay of median employee was therefore 28 to one.
Source: SEC filing on April 21, 2020.
Tabuteau's colleagues
We found three more compensation records of executives who worked with Herriot Tabuteau at Axsome Therapeutics in 2019.